Quick answers
- What is Vasostrict?
- Vasostrict is a brand name of Vasopressin (vasopressin, unspecified), a prescription medicine. The FDA NDC Directory lists 6 Vasostrict products in 3 strengths and forms.
- Who makes Vasostrict?
- PH Health holds the FDA application for Vasostrict (NDA204485, approved April 17, 2014). 2 other companies (repackagers or distributors) also list Vasostrict products.
- Is there a generic or store brand of Vasostrict?
- Yes. The FDA NDC Directory lists 5 other products with the same active ingredients, strength and form as a Vasostrict product, 4 of them generic. Ask your pharmacist whether one is right for you.
- Has Vasostrict been recalled?
- FDA enforcement reports list 1 recall of Vasostrict products; the newest started January 11, 2024. A recall usually concerns specific lots, not every product.
What Vasostrict is
Each Vasostrict product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Vasopressin (vasopressin, unspecified) · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| vasopressin, unspecified 0.2 USP units/mL injection (intravenous) | Vasostrict | None listed | DailyMed |
| vasopressin, unspecified 0.4 USP units/mL injection (intravenous) | Vasostrict | None listed | DailyMed |
| vasopressin, unspecified 20 USP units/mL injection (intravenous) | Vasostrict | 5 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Vasopressin (vasopressin, unspecified) →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA204485 | PH Health | April 17, 2014 | 6 |
Companies that list Vasostrict
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Vasostrict products.
- Par Health USA, LLC4 products
- Medical Purchasin Solutions, LLC1 product
- Medical Purchasing Solutions, LLC1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
January 11, 2024 · Class II · Ongoing · D-0232-2024
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Ch — Par Sterile Products LLC
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.